Identification and Characterization of a Potent, Selective, and Orally Active Antagonist of the CC Chemokine Receptor-1
Open Access
- 1 June 2000
- journal article
- Published by Elsevier
- Vol. 275 (25) , 19000-19008
- https://doi.org/10.1074/jbc.m001222200
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejectionJournal of Clinical Investigation, 2000
- Polyclonal antibody directed against human RANTES ameliorates disease in the Lewis rat adjuvant-induced arthritis model.Journal of Clinical Investigation, 1998
- Extension of Recombinant Human RANTES by the Retention of the Initiating Methionine Produces a Potent AntagonistJournal of Biological Chemistry, 1996
- A monoclonal antibody to α4 integrin suppresses and reverses active experimental allergic encephalomyelitisJournal of Neuroimmunology, 1995
- RANTES chemokine expression in cell-mediated transplant rejection of the kidneyThe Lancet, 1994
- Monocyte haptotaxis induced by the RANTES chemokineCurrent Biology, 1993
- Different binding epitopes on the NK1 receptor for substance P and a non-peptide antagonistNature, 1993
- A single amino acid of the cholecystokinin-B/gastrin receptor determines specificity for non-peptide antagonistsNature, 1993
- Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrinNature, 1992
- Macroglia: neural cells responsive to lymphokines and growth factorsImmunology Today, 1987